News

MADISON, WI— Gentel Biosciences, an acknowledged leader in protein microarray technology, announced it has been invited to join a collaborative Clinical Research and Development consortium using novel technologies developed by the company to gain insight into major diseases of pregnancy.

MADISON, Wis. - Gentel Biosciences, a protein microarray life sciences company, announces a technology partnership with Eprogen to create products for the discovery of new autoantibody biomarkers using whole proteome microarrays.

MADISON, Wis. - Gentel Biosciences hires Dan Clutter, Ph.D., as Vice President of Commercial Development.

MADISON, WI & Cape Town, RSA - Gentel Biosciences, Inc., a protein microarray life sciences company, announces it has placed its first APiX™ Colorimetric Protein Array Reader at the Centre for Proteomic and Genomic Research (CPGR) in Cape Town, South Africa.

MADISON, WI - Gentel® Biosciences, a protein microarray life sciences company, announces it has obtained an exclusive license to novel technology for manufacturing highly-reproducible nitrocellulose protein microarray slides.

The technology, developed by Agnitio Science and Technology of Hsinchu, Taiwan, covers the use of ultrasonic coating to produce nitrocellulose films. “Ultrasonic coating produces nitrocellulose films with a consistency unattainable using traditional coating processes like casting,” stated Dr. Bryce Nelson, Gentel’s VP of Research and Development. “Additionally, the technology is extremely flexible and can be used to fabricate optically clear or porous white nitrocellulose films.”

MADISON, WI (June 1, 2008) — Gentel® Biosciences, a leader in protein microarrays, today announced it has signed a global license agreement with Eppendorf AG, Hamburg Germany, to provide Gentel’s customers with an ultra-sensitive multiplexed protein analysis tools using colorimetric detection and its proprietary nitrocellulose films.

The agreement licenses Eppendorf’s Silverquant® colorimetric detection technology for use in protein detection assays. Silverquant is a patented method in which gold particle-enhanced silver crystal deposition is used for detection and quantification on microarrays.

MADISON, WI— Gentel® Biosciences, a protein microarray life sciences company, has expanded the Custom Services organization beginning with an initial investment in multiple Tecan automated systems to meet the growing demands in sample testing and custom assay development for multipex protein measurements.

Gentel is in the process of making substantial investments in additional instrumentation to aggressively expand the capacity of the company in direct response to ongoing and new client contracts. The additional equipment has enabled Gentel to automate and process thousands more samples per day for its growing list of clients, including a number of biotechnology companies and academic research centers.

MADISON, WI— Gentel® Biosciences, a protein microarray life sciences company, announces it has obtained an exclusive global license from PriTest® that continues the expansion of Gentel’s strategic intellectual properties covering nitrocellulose for protein microarray applications. The license to US Patent #6,861,251, covering arrays using a translucent nitrocellulose surface, builds on Gentel’s position as the acknowledged leader in protein microarrays.

“Pritest has worked hard to create innovative testing products that make a positive difference in fighting the world’s most devastating diseases like Tuberculosis. We are delighted to have Gentel as a partner”, says Chris Rathe, Co-Founder and CEO of Pritest.

MADISON, WI and PORTSMOUTH, N.H., (April 24th, 2008) – Gentel® Biosciences, a protein microarray life sciences company and Thermo Fisher Scientific Inc., the world leader in serving science, today announced the two companies have completed the first stage of a collaboration to shift microarrays to a new 96 well configuration. This new patent-pending product will evolve the current microarray offerings toward an “ELISA-like” format to increase the speed and volume of multiplex applications. The new platform conforms to the SBS microplate standard and is amenable to the automated processing of thousands of samples per day.

MADISON, WI— Gentel® Biosciences, a protein microarray life sciences company, announces the launch of the APiX™ GlycoBiomarker Array Kit. The kit provides a new method of multiplex profiling of glycans on serum glycoproteins and is based on patent pending technology licensed exclusively from the Van Andel Research Institute.

“Glycan structures are increasingly being investigated for their role in various cancers. This new approach provides a powerful means of profiling the patterns of these structures across various disease states”, said Dr. Brian Haab of the Van Andel Research Institute, inventor of the technology.